

Hepatitis Foundation of Ghana is a patient’s organization and non-profit, non-governmental organization (NGO) registered in Ghana. It seeks to promote awareness of the prevalence and incidence of viral hepatitis in Ghana, and to educate the public in the prevention of the spread of the virus and the available treatment options. We also provide care and psychosocial support to the infected and affected people and their families. In addition, it seeks to serve as the primary source of information for patients and their families.
VISION
Our vision is to eliminate new viral hepatitis infections and improve the quality of life for individuals living with chronic hepatitis B and C.
MISSION
The mission of the Hepatitis Foundation of Ghana is establishing a uniform and fair approach to the effective prevention and comprehensive management of Hepatitis B among people and their families in Ghana.
OUR CORE VALUES
Competence with responsibility and professionalism are our core values. With integrity and being transparent in everything we do, we accept responsibility for our collective and individual actions. Our focus is to work effectively to serve individuals living with viral hepatitis and the larger community in Ghana. Having respect for all, we affirm the dignity and contribution of community participants, development partners, donors and staff as we work for the better of people living with viral hepatitis in Ghana.
OBJECTIVES
Hepatitis and PWID/harm reduction
11:35 – 11:40
Chair: WHO – Intro and set the scene.
11:40 – 11:55
Co-chair: EMCDDA – Monitoring viral hepatitis elimination among PWID in Europe.
11:55 – 12:00
ID 29: Ema Pos (not yet registered)
Title: If the mountain won’t come to Mohammed: lessons from a decentralized Infectious Disease consultation.
12:05 – 12:10
ID 152: Brian Conway (Registered in person)
Title: Community Pop-up Clinic: Cascade of Care and HCV Treatment of Vancouver’s inner-city PWID Populations.
12:10 – 12:15
ID 212: Jasmine West (not yet registered)
Title: From lived experience to lived expertise: a syndemic approach.
12:15 – 12:20
ID: 299 Mercy Nyakowa (Registered in person)
Title: HCV and HBV prevalence and associated risk factors among people who inject drugs (PWIDs) in Kenya
12:20 – 12:25
ID: 133 Nalinikanta Rajkumar (Registered in person)
Title: Rapid regimen of HBV vaccination: Does it work for high risk groups?
12:25 – 12:30
Q&A and closing remarks
tHIS
IS
BEN’S
BIG
TEST
effective case finding strategies
Supported by Vir Biotechnology, Inc
During this session you will hear from hepatitis Delta expert, Dr. Maria Buti, and a patient who has lived with hepatitis Delta in a panel discussion moderated by Dr. Carey Hwang, Chief Medical Officer (interim) of Vir Biotechnology. This panel will inform perspectives on patient needs, opportunities for enhanced screening, and strengthening linkages to care.
Session Agenda
14:40 – 14:45
Panel overview and introductions facilitated by Dr Carey Hwang (Vir Biotechnology)
14:45 – 15:05
Panel discussion: Dr Maria Buti (University Hospital Vall d’Hebron, Spain), Milanka Barbosa, Dr Carey Hwang (Chief Medical Officer interim), Vir Biotechnology
15:05 – 15:10
Final remarks and close